Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammation | 9 | 2013 | 540 | 2.360 |
Why?
|
| Weight Loss | 9 | 2015 | 465 | 1.770 |
Why?
|
| Obesity | 9 | 2014 | 1158 | 1.540 |
Why?
|
| Physical Fitness | 4 | 2013 | 131 | 1.540 |
Why?
|
| Overweight | 5 | 2014 | 276 | 1.300 |
Why?
|
| Exercise | 5 | 2013 | 663 | 1.160 |
Why?
|
| Soy Milk | 3 | 2010 | 3 | 1.080 |
Why?
|
| Body Composition | 7 | 2014 | 388 | 1.040 |
Why?
|
| Postmenopause | 6 | 2012 | 413 | 0.950 |
Why?
|
| Aging | 6 | 2013 | 941 | 0.940 |
Why?
|
| Motor Activity | 4 | 2014 | 325 | 0.930 |
Why?
|
| Milk | 3 | 2010 | 16 | 0.810 |
Why?
|
| Inflammation Mediators | 3 | 2012 | 105 | 0.770 |
Why?
|
| Diet, Reducing | 4 | 2014 | 102 | 0.680 |
Why?
|
| Adipose Tissue | 2 | 2012 | 345 | 0.640 |
Why?
|
| Oxidative Stress | 2 | 2010 | 229 | 0.620 |
Why?
|
| Body Mass Index | 5 | 2014 | 916 | 0.580 |
Why?
|
| Weight Gain | 3 | 2014 | 116 | 0.580 |
Why?
|
| Adiposity | 3 | 2013 | 198 | 0.570 |
Why?
|
| Soybean Proteins | 3 | 2012 | 67 | 0.500 |
Why?
|
| Life Style | 3 | 2014 | 407 | 0.500 |
Why?
|
| Female | 21 | 2015 | 19859 | 0.470 |
Why?
|
| Aged | 13 | 2014 | 10288 | 0.470 |
Why?
|
| Adiponectin | 2 | 2013 | 106 | 0.460 |
Why?
|
| Cytokines | 3 | 2011 | 259 | 0.460 |
Why?
|
| Prediabetic State | 1 | 2014 | 65 | 0.460 |
Why?
|
| Kidney Failure, Chronic | 2 | 2009 | 540 | 0.460 |
Why?
|
| Muscle, Skeletal | 3 | 2013 | 513 | 0.440 |
Why?
|
| Middle Aged | 14 | 2015 | 11824 | 0.430 |
Why?
|
| Uric Acid | 1 | 2013 | 26 | 0.430 |
Why?
|
| Cause of Death | 1 | 2013 | 238 | 0.420 |
Why?
|
| Nonprescription Drugs | 2 | 2009 | 23 | 0.420 |
Why?
|
| Humans | 24 | 2015 | 31836 | 0.420 |
Why?
|
| Insulin Resistance | 2 | 2014 | 461 | 0.410 |
Why?
|
| Isoflavones | 2 | 2009 | 68 | 0.410 |
Why?
|
| Coronary Disease | 1 | 2013 | 213 | 0.410 |
Why?
|
| Gait | 1 | 2013 | 140 | 0.400 |
Why?
|
| Corn Oil | 2 | 2009 | 3 | 0.400 |
Why?
|
| Diet | 2 | 2011 | 385 | 0.380 |
Why?
|
| Tumor Necrosis Factors | 1 | 2010 | 5 | 0.380 |
Why?
|
| Interleukins | 1 | 2010 | 19 | 0.380 |
Why?
|
| Dietary Supplements | 3 | 2012 | 185 | 0.380 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2010 | 48 | 0.370 |
Why?
|
| Exercise Therapy | 1 | 2013 | 268 | 0.360 |
Why?
|
| Male | 14 | 2015 | 19091 | 0.350 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 125 | 0.350 |
Why?
|
| Enzymes | 1 | 2009 | 5 | 0.350 |
Why?
|
| Soybeans | 1 | 2009 | 26 | 0.340 |
Why?
|
| Plant Preparations | 1 | 2009 | 22 | 0.340 |
Why?
|
| Fish Oils | 1 | 2009 | 36 | 0.340 |
Why?
|
| Lipoprotein(a) | 1 | 2009 | 21 | 0.340 |
Why?
|
| Soy Foods | 1 | 2009 | 6 | 0.340 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 45 | 0.330 |
Why?
|
| Lipids | 1 | 2010 | 228 | 0.320 |
Why?
|
| Renal Dialysis | 2 | 2009 | 279 | 0.320 |
Why?
|
| Hyperhomocysteinemia | 1 | 2008 | 5 | 0.310 |
Why?
|
| Homocysteine | 1 | 2008 | 14 | 0.310 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 29 | 0.310 |
Why?
|
| Docosahexaenoic Acids | 1 | 2008 | 21 | 0.310 |
Why?
|
| Single-Blind Method | 5 | 2012 | 201 | 0.310 |
Why?
|
| Walking | 3 | 2013 | 208 | 0.300 |
Why?
|
| Risk Factors | 5 | 2014 | 3851 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1424 | 0.260 |
Why?
|
| Prospective Studies | 4 | 2013 | 2277 | 0.250 |
Why?
|
| North Carolina | 3 | 2014 | 1514 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 504 | 0.250 |
Why?
|
| Interleukin-6 | 4 | 2013 | 251 | 0.230 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 2271 | 0.200 |
Why?
|
| Glutathione Peroxidase | 2 | 2010 | 9 | 0.180 |
Why?
|
| Superoxide Dismutase | 2 | 2010 | 44 | 0.180 |
Why?
|
| Cyclooxygenase 2 | 2 | 2010 | 47 | 0.170 |
Why?
|
| Cardiovascular Diseases | 3 | 2013 | 1122 | 0.170 |
Why?
|
| Prevalence | 2 | 2013 | 979 | 0.170 |
Why?
|
| Animals | 4 | 2010 | 7450 | 0.150 |
Why?
|
| Double-Blind Method | 2 | 2009 | 523 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 3988 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3294 | 0.120 |
Why?
|
| Mortality | 1 | 2015 | 124 | 0.120 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 43 | 0.120 |
Why?
|
| Heart Function Tests | 1 | 2013 | 9 | 0.120 |
Why?
|
| Recurrence | 1 | 2014 | 262 | 0.120 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2013 | 16 | 0.110 |
Why?
|
| Time Factors | 2 | 2010 | 2146 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 14 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2013 | 27 | 0.110 |
Why?
|
| Movement Disorders | 1 | 2013 | 26 | 0.110 |
Why?
|
| Muscle Development | 1 | 2013 | 49 | 0.110 |
Why?
|
| Community Health Centers | 1 | 2013 | 16 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 239 | 0.110 |
Why?
|
| Leptin | 1 | 2013 | 71 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 24 | 0.110 |
Why?
|
| Triglycerides | 2 | 2012 | 230 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 152 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 564 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2013 | 102 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 71 | 0.110 |
Why?
|
| Dairy Products | 1 | 2012 | 13 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 73 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2013 | 487 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 771 | 0.100 |
Why?
|
| Disease Progression | 1 | 2014 | 593 | 0.100 |
Why?
|
| Independent Living | 1 | 2013 | 99 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 461 | 0.100 |
Why?
|
| Abdominal Fat | 1 | 2012 | 49 | 0.100 |
Why?
|
| Health Education | 1 | 2013 | 157 | 0.100 |
Why?
|
| Body Fluid Compartments | 1 | 2011 | 5 | 0.100 |
Why?
|
| Sex Factors | 1 | 2013 | 662 | 0.100 |
Why?
|
| Food, Formulated | 1 | 2011 | 12 | 0.100 |
Why?
|
| Sarcopenia | 1 | 2012 | 62 | 0.100 |
Why?
|
| Health Behavior | 1 | 2013 | 231 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2011 | 43 | 0.090 |
Why?
|
| Mobility Limitation | 1 | 2013 | 219 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 57 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2012 | 238 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2013 | 1431 | 0.090 |
Why?
|
| Health Status | 1 | 2013 | 397 | 0.090 |
Why?
|
| Geriatric Assessment | 1 | 2013 | 390 | 0.090 |
Why?
|
| Cattle | 1 | 2010 | 103 | 0.090 |
Why?
|
| Age Factors | 1 | 2013 | 1187 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2010 | 81 | 0.090 |
Why?
|
| Models, Biological | 1 | 2012 | 391 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2009 | 52 | 0.080 |
Why?
|
| Prognosis | 1 | 2013 | 1498 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 211 | 0.080 |
Why?
|
| Health Promotion | 1 | 2011 | 246 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2010 | 400 | 0.080 |
Why?
|
| Texas | 1 | 2008 | 36 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 251 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2008 | 189 | 0.070 |
Why?
|
| United States | 1 | 2010 | 3925 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2014 | 148 | 0.050 |
Why?
|
| Adult | 2 | 2011 | 9327 | 0.050 |
Why?
|
| Publication Bias | 1 | 2015 | 8 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2012 | 3 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 11 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2012 | 15 | 0.030 |
Why?
|
| Running | 1 | 2012 | 19 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 177 | 0.030 |
Why?
|
| Calpain | 1 | 2012 | 13 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 76 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 173 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 186 | 0.020 |
Why?
|
| Hand Strength | 1 | 2012 | 100 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2011 | 9 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 104 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2011 | 184 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 366 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 508 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2012 | 491 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 686 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 224 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 332 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2012 | 843 | 0.020 |
Why?
|